SORINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sorine, and when can generic versions of Sorine launch?
Sorine is a drug marketed by Aiping Pharm Inc and is included in one NDA.
The generic ingredient in SORINE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sorine
A generic version of SORINE was approved as sotalol hydrochloride by TEVA on May 1st, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SORINE?
- What are the global sales for SORINE?
- What is Average Wholesale Price for SORINE?
Summary for SORINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Patent Applications: | 2,999 |
Drug Prices: | Drug price information for SORINE |
DailyMed Link: | SORINE at DailyMed |
Pharmacology for SORINE
Drug Class | Antiarrhythmic |
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Cardiac Rhythm Alteration |
US Patents and Regulatory Information for SORINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aiping Pharm Inc | SORINE | sotalol hydrochloride | TABLET;ORAL | 075500-001 | Apr 27, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aiping Pharm Inc | SORINE | sotalol hydrochloride | TABLET;ORAL | 075500-003 | Apr 27, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aiping Pharm Inc | SORINE | sotalol hydrochloride | TABLET;ORAL | 075500-004 | Apr 27, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aiping Pharm Inc | SORINE | sotalol hydrochloride | TABLET;ORAL | 075500-002 | Apr 27, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |